Prof Cherrie Galletly

School of Medicine

College of Health


Emerita Professor Cherrie Galletly is a consultant psychiatrist working across the University, public mental health and private sectors. She was Interim Dean of the Adelaide Medical School 2020-2021, responsible for managing the MBBS program during the COVID-19 pandemic. She was awarded an OAM for her services to psychiatry, in 2022. She held a Chair in Psychiatry, jointly funded by the University of Adelaide and Ramsay Health Care (SA) Mental Health, from 2007 until May 2022. She continues as a Regional Director of Postgraduate Psychiatry training (Northern Area Local Health Network). She takes a collaborative approach to research, with the ultimate goal of improving the quality of care for people with severe mental illness. Her research interests include schizophrenia and other psychotic disorders; she was Northern Adelaide site director for the Second National Survey of Psychosis (2010) a landmark study of more than 1800 people with psychoses. She was a member of the NHMRC Mental Health Research Advisory Committee (MHRAC) 2017-2019.She was a Chief Investigator on a study of comorbidity between mental health and substance abuse disorder based in the Northern suburbs of Adelaide. She heads up one of the leading national centres on neurostimulation treatments (rTMS and ECT) for psychiatric disorders. She led the Writing Group for the RANZCP Clinical Practise Guidelines for Schizophrenia and Related Disorders. She was an Associate Editor for the Australian and New Zealand Journal of Psychiatry (2011-2021) and a member of the Editorial Executive for Australian Prescriber (2011-2020). She has worked with many early career researchers and clinicians to publish their first paper. She has supervised many HDR students including supervising seven PhDs to completion.She has more than 300 publications in the peer reviewed literature, along with one book and 3 book chapters. Since 2011 she has been involved in 61 conference presentations. Her total collaborative research funding exceeds $30m.

Date Position Institution name
2012 - ongoing Regional Director of Training Northern Mental Health, NALHN
2007 - ongoing Emerita Professor University of Adelaide

Year Citation
2026 Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2026). Response to “Letter to the editor regarding: “Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression” by Nguyen et al. (2025)”. Journal of Affective Disorders, 394(Pt A), 2 pages.
DOI
2025 Sharmil, H., Galletly, C., Kelly, J., Wilkes, T., George, A., Jaison, M., . . . Annamalai, K. (2025). Awareness of access to health care: a significant need of the Narikuravar people, India. Rural and Remote Health, 25(4), 7 pages.
DOI
2025 Christodoulou, V., Liu, D., Esterman, A., & Galletly, C. (2025). 'Facilitators and barriers to recruitment in mental health research: A survey of psychiatrists and psychiatry registrars in training'. Australasian Psychiatry, 33(1), 153-161.
DOI Scopus1 WoS1 Europe PMC1
2025 Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2025). Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression. Journal of Affective Disorders, 385, 11 pages.
DOI Scopus2 WoS2
2025 Gill, S., & Galletly OAM, C. (2025). ‘I, robot, can help you’. Applications of Generative Artificial Intelligence in RANZCP psychiatry training. Australasian Psychiatry, 33(4), 689-692.
DOI
2025 Halstead, S., Yap, C. X., Warren, N., Agarwal, S. M., Brand, B. A., Chan, S. K. W., . . . McCutcheon, R. A. (2025). Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission. Lancet Psychiatry, 12(9), 673-699.
DOI Scopus1 Europe PMC1
2025 Burford, C., Proctor, J., Thomson, S., Toh, J., Schubert, K. O., & Galletly, C. (2025). Clinical characteristics of people referred for Medicare Item 291 Psychiatric Assessments in northern metropolitan Adelaide. Australasian Psychiatry, 33(6), 916-922.
DOI
2025 Galletly, C. (2025). Antipsychotic augmentation of clozapine. Australasian Psychiatry, 33(2), 303.
DOI Scopus1 WoS1
2024 Galbally, M., Kotze, B., Bell, C., Quadrio, C., Galletly, C., Herrman, H., . . . Morgan, S. (2024). Achieving gender equity in academic psychiatry – barriers to involvement and solutions for success. Australasian Psychiatry, 32(6), 563-567.
DOI Scopus2 Europe PMC1
2024 Weickert, T. W., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W. S., . . . Shannon Weickert, C. (2024). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, Behavior, and Immunity, 115, 191-200.
DOI Scopus19 WoS17 Europe PMC17
2024 Weickert, T. W., Ji, E., Galletly, C., Boerrigter, D., Morishima, Y., Bruggemann, J., . . . Kindler, J. (2024). Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning. Schizophrenia Bulletin, 50(2), 403-417.
DOI Scopus8 WoS8 Europe PMC6
2024 Tran, L., Hahn, L., Gill, S., Ng, F., Clarke, P., Paterson, T., & Galletly, C. (2024). Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry, 32(3), 180-185.
DOI Scopus1 WoS1 Europe PMC1
2023 Arnautovska, U., Vitangcol, K., Kesby, J. P., Warren, N., Rossell, S. L., Neill, E., . . . Siskind, D. (2023). Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study. Schizophrenia Research: Cognition, 33, 100283-1-100283-7.
DOI Scopus7
2023 Lindell‐Innes, R., Phillips‐Hughes, A. L., Bartsch, D., Galletly, C., & Ludbrook, C. (2023). Attitudes of psychiatry trainees towards patients with borderline personality disorder: Does the stigma begin during training?. Personality and Mental Health, 17(4), 387-395.
DOI Scopus12 WoS12 Europe PMC7
2022 Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2022). Associations between health literacy, cognitive function and general literacy in people with schizophrenia attending community mental health clinics in Australia.. BMC Psychiatry, 22(1), 9 pages.
DOI Scopus5 WoS5 Europe PMC4
2022 Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Benyamin, B., & O'Donovan, M. C. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.
DOI Scopus1583 WoS1545 Europe PMC1973
2022 Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hahn, L., Lavale, A., . . . Fitzgerald, P. B. (2022). Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes?. Brain Stimulation, 15(4), 889-891.
DOI Scopus2 WoS2 Europe PMC1
2022 Sigrist, C., Vöckel, J., MacMaster, F. P., Farzan, F., Croarkin, P. E., Galletly, C., . . . Koenig, J. (2022). Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. European Child and Adolescent Psychiatry, 31(10), 1501-1525.
DOI Scopus42 Europe PMC27
2022 Neill, E., Rossell, S. L., Yolland, C., Meyer, D., Galletly, C., Harris, A., . . . Castle, D. J. (2022). N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin, 48(6), 1263-1272.
DOI Scopus27 WoS25 Europe PMC22
2022 Condon, J., Stewart, C., & Galletly, C. (2022). Is PTSD a Bodily Injury?. Journal of Law and Medicine, 29(3), 888-894.
2022 Nguyen, H., Haeney, O., & Galletly, C. (2022). The characteristics of older homicide offenders: a systematic review. Psychiatry, Psychology and Law, 29(3), 413-430.
DOI Scopus7 WoS6 Europe PMC1
2022 Ji, E., Boerrigter, D., Cai, H. Q., Lloyd, D., Bruggemann, J., O'Donnell, M., . . . Shannon Weickert, C. (2022). Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain, Behavior, and Immunity, 101, 423-434.
DOI Scopus29 WoS28 Europe PMC27
2022 Amir Izzat, J., Cherrie, G., & Nick, F. (2022). Improving services for those who serve: A private practice initiative to improve psychiatric care for first responder and military patients. Australasian Psychiatry, 30(3), 103985622110578.
DOI
2022 Fitzgerald, P. B., Gill, S., Breakspear, M., Kulkarni, J., Chen, L., Pridmore, S., . . . Hoy, K. E. (2022). Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Australian & New Zealand Journal of Psychiatry, 56(8), 905-909.
DOI Scopus9 WoS10 Europe PMC5
2022 Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C., . . . Galletly, C. (2022). The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review. Biomedicine and Pharmacotherapy, 146, 18 pages.
DOI Scopus45 WoS36 Europe PMC32
2022 Murphy, C. E., Walker, A. K., O’Donnell, M., Galletly, C., Lloyd, A. R., Liu, D., . . . Weickert, T. W. (2022). Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Translational Psychiatry, 12(1), 11 pages.
DOI Scopus28 WoS28 Europe PMC26
2022 Galletly, C. A. (2022). Effective family interventions for people with schizophrenia. Lancet Psychiatry, 9(3), 185-187.
DOI Scopus3 WoS3 Europe PMC3
2021 Giam, A., Chen, L., Lisa Hahn., Gill, S., Clarke, P., Ng, F., . . . Fitzgerald, P. (2021). Comparing theta burst stimulation with standard left high frequency transcranial magnetic stimulation in the treatment of depression in a randomized controlled study: A preliminary comparison study. Journal of Affective Disorders Reports, 5, 100162-1-100162-7.
DOI Scopus7
2021 Arnautovska, U., Neill, E., Rossell, S. L., Yolland, C., Galletly, C., Harris, A., . . . Siskind, D. (2021). Does the clozapine/norclozapine ratio predict cognitive performance in patients with clozapine-resistant schizophrenia?. Australian and New Zealand Journal of Psychiatry, 56(7), 875-878.
DOI Scopus5 WoS6 Europe PMC5
2021 Ford, H., Hahn, L., Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2021). A comparison of 15 minute vs 30 minute repetitive transcranial magnetic stimulation sessions for treatment resistant depression – are longer treatment sessions more effective?. Journal of Affective Disorders, 282, 974-978.
DOI Scopus3 WoS3 Europe PMC2
2021 Galletly, C., Suetani, S., Hahn, L., McKellar, D., & Castle, D. (2021). Ageing with psychosis – Fifty and beyond. Australian & New Zealand Journal of Psychiatry, 56(1), 39-49.
DOI Scopus3 WoS3 Europe PMC3
2021 Bampton, T. J., Hack, D., & Galletly, C. A. (2021). Clozapine treatment for Huntington's disease psychosis.. The Australian and New Zealand journal of psychiatry, 56(2), 48674211013082.
DOI Scopus6 WoS4 Europe PMC2
2021 Enticott, P. G., Barlow, K., Guastella, A. J., Licari, M. K., Rogasch, N. C., Middeldorp, C. M., . . . Fitzgerald, P. B. (2021). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open, 11(7), e046830-1-e046830-9.
DOI Scopus14 WoS12 Europe PMC11
2021 Sharmil, H., Kelly, J., Bowden, M., Galletly, C., Cairney, I., Wilson, C., . . . de Crespigny, C. (2021). Participatory Action Research-Dadirri-Ganma, using Yarning: methodology co-design with Aboriginal community members. International Journal for Equity in Health, 20(1), 160-1-160-11.
DOI Scopus56 WoS39 Europe PMC25
2021 Chen, L., Thomas, E. H., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial. Brain Stimul, 14(5), 1095-1105.
DOI Scopus68 WoS65 Europe PMC60
2021 Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Corrigendum to, 'Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial' [Brain Stimulat. 14(5) (2021) 1095-1105].. Brain stimulation, 14(5), 1218.
DOI
2021 Jernbom Falk, A., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2021). Autoantibody profiles associated with clinical features in psychotic disorders. Translational Psychiatry, 11(1), 1-9.
DOI Scopus25 WoS25 Europe PMC25
2020 Galletly, C., Ash, D., Sweeney, S., O'Neill, F., & Crichton, J. (2020). Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder.. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 28(2), 193-198.
DOI WoS1
2020 Ji, E., Weickert, C. S., Purves-Tyson, T., White, C., Handelsman, D. J., Desai, R., . . . Weickert, T. W. (2020). Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia. Psychoneuroendocrinology, 123, 104916.
DOI Scopus12 WoS11 Europe PMC9
2020 Galletly, C. (2020). A Whale of an issue.. Aust N Z J Psychiatry, 54(11), 1053-1055.
DOI
2020 Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C., . . . Rossell, S. L. (2020). Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutritional Neuroscience, 23(2), 139-148.
DOI Scopus37 WoS31 Europe PMC30
2020 Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O Donnell, M., . . . Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25(4), 761-775.
DOI Scopus180 WoS173 Europe PMC158
2020 Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2020). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study.. JMIR mental health, 7(1), e11551.
DOI Scopus21 WoS19 Europe PMC14
2020 Zulfic, Z., Weickert, C. S., Weickert, T. W., Liu, D., Myles, N., & Galletly, C. (2020). Neutrophil-lymphocyte ratio - a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders?. Australas Psychiatry, 28(4), 454-458.
DOI Scopus39 WoS34 Europe PMC32
2020 Myles, H., Myles, N., Vincent, A. D., Wittert, G., Adams, R., Chandratilleke, M., . . . Galletly, C. (2020). Pilot cohort study of obstructive sleep apnoea in community-dwelling people with schizophrenia.. Ir J Psychol Med, 38(1), 1-7.
DOI Scopus5 WoS7 Europe PMC5
2020 Galletly, C. (2020). Psychiatry in the COVID-19 Era. Australian and New Zealand Journal of Psychiatry, 54(5), 447-448.
DOI Scopus21 Europe PMC14
2020 Siskind, D., Northwood, K., Berk, M., Castle, D., Galletly, C., & Harris, A. (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. Australian and New Zealand Journal of Psychiatry, 54(7), 759-761.
DOI Scopus2 Europe PMC2
2020 Cai, H. Q., Weickert, T. W., Catts, V. S., Balzan, R., Galletly, C., Liu, D., . . . Shannon Weickert, C. (2020). Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain, Behavior, and Immunity, 89, 200-208.
DOI Scopus24 WoS23 Europe PMC23
2020 Clifford, L., Crabb, S., Turnbull, D., Hahn, L., & Galletly, C. (2020). A qualitative study of medication adherence amongst people with schizophrenia. Archives of Psychiatric Nursing, 34(4), 194-199.
DOI Scopus24 WoS20 Europe PMC17
2020 Plevin, D., & Galletly, C. (2020). The neuropsychiatric effects of vitamin C deficiency: a systematic review.. BMC Psychiatry, 20(1), 1-9.
DOI Scopus89 WoS68 Europe PMC50
2020 Thomson, S., Doan, T., Liu, D., Schubert, K. O., Toh, J., Boyd, M. A., & Galletly, C. (2020). Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australasian Psychiatry, 28(5), 492-499.
DOI Scopus14 WoS14 Europe PMC13
2020 Galletly, C. (2020). Sexual misconduct by doctors: a problem that has not gone away. Medical Journal of Australia, 213(5), 216-217.
DOI Scopus2 WoS3
2020 Henderson, S., Berk, M., Boyce, P., Jorm, A., Galletly, C., Porter, R., . . . Malhi, G. (2020). Finding reviewers: A crisis for journals and their authors. Australian and New Zealand Journal of Psychiatry, 54(10), 957-959.
DOI Scopus6 WoS3 Europe PMC2
2019 Balzan, R. P., Mattiske, J. K., Delfabbro, P., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial.. Schizophrenia bulletin, 45(1), 27-36.
DOI Scopus33 WoS32 Europe PMC25
2019 Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., . . . Stubbs, B. (2019). The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry, 6(8), 675-712.
DOI Scopus1166 WoS1112 Europe PMC898
2019 Firth, J., Rosenbaum, S., Galletly, C., Siddiqi, N., Stubbs, B., Killackey, E., . . . Siskind, D. (2019). Protecting physical health in people with mental illness – Authors' reply. The Lancet Psychiatry, 6(11), 890-891.
DOI Scopus19 WoS8 Europe PMC9
2019 Galletly, C. (2019). More access for some but not others: Is it better?. Australian and New Zealand Journal of Psychiatry, 53(11), 1041-1043.
DOI Scopus1 Europe PMC1
2019 Szabo, S., Lloyd, B., McKellar, D., Myles, H., Newton, H., Schutz, J., . . . Galletly, C. (2019). ‘Having a mentor helped me with difficult times’: a trainee-run mentoring project. Australasian Psychiatry, 27(3), 230-233.
DOI Scopus13 WoS12 Europe PMC6
2019 Galletly, C. A., & Xinhui, L. (2019). To suit the occasion, I wore my fancy dress.. Australasian Psychiatry.
2019 Szabo, S., Lloyd, B., McKellar, D., Newton, H., Shutz, J., Hahn, L., & Galletly, C. (2019). 'Having a mentor helped me with difficult times:' a trainee-run mentoring project.. Australasian Psychiatry, 27(3), 230-233.
2019 Balzan, R., Delfabbro, P., Mattiske, J., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A randomised Clinical Trial.. Schizophrenia Bulletin, 45(1), 27-36.
2019 Galletly, C. (2019). Paracetamol, pregnancy and public health. Australian and New Zealand Journal of Psychiatry, 53(3), 181-183.
DOI
2019 Myles, N., Myles, H., Xia, S., Large, M., Bird, R., Galletly, C., . . . Siskind, D. (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian and New Zealand Journal of Psychiatry, 53(5), 403-412.
DOI Scopus66 WoS62 Europe PMC49
2019 Lim, X., & Galletly, C. (2019). “To suit the occasion, I wore my schizophrenic fancy dress” – the life of Janet Frame. Australasian Psychiatry, 27(5), 1039856219839489.
DOI Scopus2 WoS1
2019 Clarke, E., Clarke, P., Gill, S., Paterson, T., Hahn, L., & Galletly, C. (2019). Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders.. Journal of affective disorders, 252, 435-439.
DOI Scopus55 WoS45 Europe PMC38
2019 Owens, S. J., Weickert, T. W., Purves-Tyson, T. D., Ji, E., White, C., Galletly, C., . . . Shannon Weickert, C. (2019). Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.. Molecular neuropsychiatry, 5(1), 28-41.
DOI Europe PMC2
2019 Weickert, C. S., Lee, C. H., Lenroot, R. K., Bruggemann, J., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia. Schizophrenia Research, 209, 212-217.
DOI Scopus13 WoS13 Europe PMC11
2019 Lee, C. H., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. W. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research, 213, 87-95.
DOI Scopus16 WoS15 Europe PMC9
2019 Kindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 43(11), 13 pages.
DOI Scopus216 WoS205 Europe PMC192
2019 Turner, S., Harvey, C., Hayes, L., Castle, D., Galletly, C., Sweeney, S., . . . Spittal, M. J. (2019). Childhood adversity and clinical and psychosocial outcomes in psychosis. Epidemiology and Psychiatric Sciences, 29, e78.
DOI Scopus46 WoS41 Europe PMC31
2019 Myles, H., Myles, N., Coetzer, C. L. C., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2019). Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: a pilot study. Schizophrenia Research: Cognition, 15, 14-20.
DOI Scopus20 WoS17 Europe PMC13
2018 Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2018). Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?. Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders, 12(6), 1045-1051.
DOI Scopus8 WoS7 Europe PMC6
2018 Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2018). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study (Preprint).
DOI
2018 Galletly, C., & Myles, H. (2018). Making an impact. Australian and New Zealand Journal of Psychiatry, 52(8), 725-726.
DOI Scopus1 Europe PMC1
2018 Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., O'Donnell, M., Lenroot, R., . . . Weickert, T. (2018). C-Reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9(OCT), 2230-1-2230-16.
DOI Scopus88 WoS85 Europe PMC84
2018 Rosenich, E., Gill, S., Clarke, P., Paterson, T., Hahn, L., & Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants?. Early Intervention in Psychiatry, 13(5), 1-7.
DOI Scopus19 WoS13 Europe PMC13
2018 Galletly, C., Suetani, S., & Dark, F. (2018). Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52(9), 819-821.
DOI Scopus3 WoS3 Europe PMC1
2018 Haeney, O., Ash, D., & Galletly, C. (2018). School Shootings – ‘It wouldn’t happen here’?. Australian and New Zealand Journal of Psychiatry, 52(5), 405-407.
DOI Scopus2 WoS2 Europe PMC1
2018 Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 26(6), 600-603.
DOI Scopus19 WoS12 Europe PMC11
2018 Myles, N., Myles, H., Xia, S., Large, M., Kisely, S., Galletly, C., . . . Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta psychiatrica Scandinavica, 138(2), 101-109.
DOI Scopus181 Europe PMC137
2018 Balzan, R. P., Dhillon, V. S., Liu, D., Hahn, L., Fenech, M. F., & Galletly, C. (2018). Shorter telomere length in people with schizophrenia who live alone?. Schizophrenia Research, 199, 422-423.
DOI Scopus6 WoS4 Europe PMC3
2018 Campbell, L., Hanlon, M. -C., Galletly, C., Harvey, C., Stain, H., Cohen, M., . . . Brown, S. (2018). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52(5), 435-445.
DOI Scopus24 WoS25 Europe PMC20
2018 Koblar, S., Cranwell, M., Koblar, S., Carnell, B., & Galletly, C. (2018). Developing empathy: does experience through simulation improve medical student empathy?. Medical Science Educator, 28(1), 31-36.
DOI Scopus15
2017 Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., Liu, D., . . . Weickert, C. (2017). Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. Journal of Neuroinflammation, 14(1), 188-1-188-15.
DOI Scopus136 WoS132 Europe PMC123
2017 Galletly, C. A. (2017). Psychiatry training: survive and thrive. Medical Journal of Australia, 206(11), 485.
DOI
2017 Galletly, C. (2017). Risks, benefits and finding the best way forward. Australian and New Zealand Journal of Psychiatry, 51(10), 963-964.
DOI
2017 Castle, D. J., Galletly, C. A., Dark, F., Humberstone, V., Morgan, V. A., Killackey, E., . . . Jablensky, A. (2017). The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. Medical Journal of Australia, 206(11), 501-505.
DOI Scopus24 WoS25 Europe PMC21
2017 Glass, L., Sinclair, D., Boerrigter, D., Naude, K., Fung, S., Brown, D., . . . Shannon Weickert, C. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Translational Psychiatry, 7(8), 1-9.
DOI Scopus18 WoS20 Europe PMC17
2017 Jablensky, A., Castle, D. J., Dark, F., Humberstone, V., Killackey, E., Kulkarni, J., . . . Galletly, C. (2017). The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders – what’s next?. Australasian Psychiatry, 25(6), 600-602.
DOI Scopus6 WoS6 Europe PMC6
2017 Groenkjaer, M., de Crespigny, C., Liu, D., Moss, J., Cairney, I., Lee, D., . . . Galletly, C. (2017). "The chicken or the egg": barriers and facilitators to collaborative care for people with comorbidity in a metropolitan region of South Australia. Issues in Mental Health Nursing, 38(1), 18-24.
DOI Scopus14 WoS13 Europe PMC12
2017 Galletly, C. A., Carnell, B. L., Clarke, P., & Gill, S. (2017). A comparison of right unilateral and sequential bilateral repetitive transcranial magnetic stimulation for major depression: a naturalistic clinical Australian study. Journal of ECT, 33(1), 58-62.
DOI Scopus11 WoS11 Europe PMC8
2017 Myles, N., Large, M., Myles, H., Adams, R., Liu, D., & Galletly, C. (2017). Australia's economic transition, unemployment, suicide and mental health needs. Australian and New Zealand Journal of Psychiatry, 51(2), 119-123.
DOI Scopus15 WoS13 Europe PMC10
2017 Allison, S., Bastiampillai, T., Galletly, C., & Nance, M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry.. Australian and New Zealand Journal of Psychiatry, 51(8), 1.
DOI
2017 Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4(4), 263-265.
DOI Scopus24 WoS21 Europe PMC17
2017 Hahn, L. A., Mackinnon, A., Foley, D. L., Morgan, V. A., Waterreus, A., Watts, G. F., . . . Galletly, C. A. (2017). The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis. Schizophrenia Research, 184, 88-95.
DOI Scopus3 WoS3 Europe PMC1
2017 Morgan, V., Waterreus, A., Carr, V., Castle, D., Cohen, M., Harvey, C., . . . Galletly, C. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51(2), 124-140.
DOI Scopus100 WoS92 Europe PMC71
2017 Smith, C., Myles, H., & Galletly, C. (2017). Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk. Australasian Psychiatry, 25(4), 387-390.
DOI Scopus4 WoS4 Europe PMC3
2017 Carnell, B. L., Clarke P., Gill, S., Galletly, C. A., & Galletly, C. A. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression?. The Journal of Affective Disorders, 209, 270-272.
DOI Scopus19 WoS16 Europe PMC13
2017 Galletly, C., Dhillon, V. S., Liu, D., Balzan, R. P., Hahn, L. A., & Fenech, M. F. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51.
DOI Scopus18 WoS17 Europe PMC17
2017 Posselt, M., McDonald, K., Procter, N., De Crespigny, C., & Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1), 280-1-280-17.
DOI Scopus49 WoS49 Europe PMC30
2017 Large, M., Galletly, C., Myles, N., Ryan, C. J., & Myles, H. (2017). Known unknowns and unknown unknowns in suicide risk assessment: Evidence from meta-analyses of aleatory and epistemic uncertainty. Bjpsych Bulletin, 41(3), 160-163.
DOI Scopus34 Europe PMC20
2017 Nielssen, O., McGorry, P., Castle, D., & Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: why is our practice so far short of our recommendations, and what can we do about it?. Australian and New Zealand Journal of Psychiatry, 51(7), 670-674.
DOI Scopus7 WoS6 Europe PMC7
2017 Siskind, D., Harris, M., Phillipou, A., Morgan, V., Waterreus, A., Galletly, C., . . . Castle, D. (2017). Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. Epidemiology and psychiatric sciences, 26(3), 325-337.
DOI Scopus26 WoS24 Europe PMC24
2017 Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2017). The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophrenia Research, 182, 13-18.
DOI Scopus3 WoS3 Europe PMC2
2017 Kulkarni, J., & Galletly, C. A. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51(2), 192-194.
DOI Scopus10 WoS7 Europe PMC9
2017 Myles, H., Myles, N., Liu, D., Adams, R., Wittert, G., Antic, N. A., & Galletly, C. (2017). How long will we sleep on obstructive sleep apnoea in schizophrenia?. Australian & New Zealand Journal of Psychiatry, 51(1), 95-96.
DOI Scopus3 WoS3 Europe PMC2
2016 Large, M., Galletly, C. A., Myles, N., Ryan, C. J., & Myles, H. (2016). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJPsych Bulletin.
2016 Weinberg, D., Lenroot, R., Jacomb, I., Allen, K., Bruggemann, J., Wells, R., . . . Weickert, T. (2016). Cognitive subtypes in schizophrenia characterized by differential brain volumetric reductions and cognitive decline. JAMA Psychiatry, 73(12), 1251-1259.
DOI Scopus83 WoS81 Europe PMC78
2016 Liu, D., Myles, H., Foley, D., Watts, G., Morgan, V., Castle, D., . . . Galletly, C. (2016). Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health. Frontiers in Psychiatry, 7(AUG), 139-1-139-12.
DOI Scopus18 WoS13 Europe PMC9
2016 Morgan, V., Morgan, F., Galletly, C., Valuri, G., Shah, S., & Jablensky, A. (2016). Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology, 51(2), 269-279.
DOI Scopus23 WoS20 Europe PMC19
2016 Myles, H., Myles, N., Antic, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2016). Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophrenia Research, 170(1), 222-225.
DOI Scopus63 WoS51 Europe PMC46
2016 Galletly, C., Clark, L., McFarlane, A., Searle, A., Sawyer, M., Sim, M., . . . van Hooff, M. (2016). Childhood lead exposure, childhood trauma, substance use and subclinical psychotic experiences - a longitudinal cohort study. Psychiatry Research, 239, 54-61.
DOI Scopus5 WoS5
2016 Galletly, C., Turnbull, C., & Goldney, R. (2016). Medical student teaching in the private sector - An overlooked opportunity?. Australasian Psychiatry, 24(2), 198-200.
DOI Scopus4 WoS3 Europe PMC2
2016 Galletly, C. A., Gill, S., Rigby, A., Carnell, B. L., & Clarke, P. (2016). Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing. Journal of ECT, 32(3), 169-173.
DOI Scopus11 WoS11 Europe PMC9
2016 Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50(5), 410-472.
DOI Scopus713 WoS661 Europe PMC528
2016 Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Awareness of pre-diabetes or diabetes and associated factors in people with psychosis. Schizophrenia Bulletin, 42(5), 1280-1289.
DOI Scopus13 WoS11 Europe PMC6
2016 Liu, D., de Crespigny, C., Procter, N., Kelly, J., Francis, H., Posselt, M., . . . Galletly, C. A. (2016). Comorbidity action in the north – a study of services for people with comorbid mental health and drug and alcohol disorders in the northern suburbs of Adelaide. Australasian Psychiatry, 24(6), 592-597.
DOI Scopus12 WoS12 Europe PMC9
2016 Suetani, S., Waterreus, A., Morgan, V., Foley, D., Galletly, C., Badcock, J., . . . McGrath, J. (2016). Correlates of physical activity in people living with psychotic illness. Acta Psychiatrica Scandinavica, 134(2), 129-137.
DOI Scopus43 WoS38 Europe PMC35
2016 Cohen, O., Weickert, T., Hess, J., Paish, L., McCoy, S., Rothmond, D., . . . Glatt, S. (2016). A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Molecular Psychiatry, 21(7), 975-982.
DOI Scopus30 WoS20 Europe PMC21
2016 Galletly, C. (2016). Compulsive reading: Stars with addictions, to Star Wars. Australian and New Zealand Journal of Psychiatry, 50(8), 713-715.
DOI
2016 Waterreus, A., Di Prinzio, P., Watts, G., Castle, D., Galletly, C., & Morgan, V. (2016). Metabolic syndrome in people with a psychotic illness: Is cannabis protective?. Psychological Medicine, 46(8), 1651-1662.
DOI Scopus22 Europe PMC20
2016 Foley, D., Mackinnon, A., Morgan, V., Castle, D., Waterreus, A., Galletly, C., & Galletly, C. (2016). Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis. Schizophrenia Bulletin, 44(1), 9 pages.
DOI Scopus14 WoS12 Europe PMC10
2016 Sweeney, S., Air, T., Zannettino, L., Shah, S. S., & Galletly, C. (2016). Corrigendum: Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis [Front. Psychol, 6, (2015):(1768)] Doi: 10.3389/fpsyg.2015.01768. Frontiers in Psychology, 7(AUG), 2 pages.
DOI Scopus1 WoS1 Europe PMC1
2016 Rossell, S., Francis, P., Galletly, C., Harris, A., Siskind, D., Berk, M., . . . Castle, D. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16(1), 320-1-320-9.
DOI Scopus37 WoS30 Europe PMC27
2016 Large, M., Galletly, C., Myles, N., Ryan, C., & Myles, H. (2016). Known unknown and unknown unknowns in suicide risk assessment: what do recent meta-analyses tell us about aleatory and epistemic uncertainty?. BJ Psych Bulletin, 1-4.
2016 Galletly, C. A. (2016). Look who's talking. Aust N Z J Psychiatry, 50(11), 1031-1032.
DOI
2016 Pillai, A., Howell, K., Ahmed, A., Weinberg, D., Allen, K., Bruggemann, J., . . . Weickert, T. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 21(5), 686-692.
DOI Scopus70 WoS64 Europe PMC59
2016 Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Common familial risk factors for schizophrenia and diabetes mellitus. Australian and New Zealand Journal of Psychiatry, 50(5), 488-494.
DOI Scopus24 WoS21 Europe PMC17
2015 Happell, B., Galletly, C., Castle, D., Platania-Phung, C., Stanton, R., Scott, D., . . . Furness, T. (2015). Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care. International Journal of Mental Health Nursing, 24(5), 421-438.
DOI Scopus15 WoS16 Europe PMC13
2015 Balzan, R., & Galletly, C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: a case study. Frontiers in Psychology, 6, 967-1-967-6.
DOI Scopus14 WoS11 Europe PMC8
2015 Posselt, M., Procter, N., de Crespigny, C., & Galletly, C. (2015). Merging perspectives: obstacles to recovery for youth from refugee backgrounds with comorbidity. Australasian Psychiatry, 23(3), 293-299.
DOI Scopus18 WoS17 Europe PMC10
2015 Weickert, T., Weinberg, D., Lenroot, R., Catts, S., Wells, R., Vercammen, A., . . . Weickert, C. (2015). Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Molecular Psychiatry, 20(6), 685-694.
DOI Scopus120 WoS116 Europe PMC100
2015 Happell, B., Platania-Phung, C., Webster, S., McKenna, B., Millar, F., Stanton, R., . . . Scott, D. (2015). Applying the World Health Organization Mental Health Action Plan to evaluate policy on addressing co-occurrence of physical and mental illnesses in Australia. Australian Health Review, 39(4), 370-378.
DOI Scopus12 WoS12 Europe PMC9
2015 Kisely, S., Chang, A., Crowe, J., Galletly, C., Jenkins, P., Loi, S., . . . Macfarlane, S. (2015). Getting started in research: Systematic reviews and meta-analyses. Australasian Psychiatry, 23(1), 16-21.
DOI Scopus8 Europe PMC4
2015 Lacey, M., Paolini, S., Hanlon, M., Melville, J., Galletly, C., & Campbell, L. (2015). Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers. Psychiatry Research, 225(3), 723-733.
DOI Scopus41 WoS41 Europe PMC27
2015 Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2015). How safe is repetitive Transcranial Magnetic Stimulation?. Australian and New Zealand Journal of Psychiatry, 49(5), 485.
DOI Scopus7 WoS5 Europe PMC3
2015 Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian and New Zealand Journal of Psychiatry, 49(12), 1227.
DOI Scopus21 WoS18 Europe PMC16
2015 Suetani, S., Gill, S., & Galletly, C. (2015). A scholarly endeavour: Some practical tips on completing the scholarly project. Australasian Psychiatry, 23(1), 29-31.
DOI Scopus10 WoS10 Europe PMC9
2015 Galletly, C. A., Loo, C. K., Malhi, G. S., Mitchell, P. B., & Fitzgerald, P. (2015). Why repetitive transcranial magnetic stimulation should be available for treatment resistant depression. Australian and New Zealand Journal of Psychiatry, 49(2), 182-183.
DOI Scopus1 WoS1
2015 Nenke, M., Hahn, L., Thompson, C., Liu, D., & Galletly, C. (2015). Psychosis and cardiovascular disease: Is diet the missing link?. Schizophrenia Research, 161(2-3), 465-470.
DOI Scopus18 WoS16 Europe PMC12
2015 Foley, D., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2015). Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample. The Australian and New Zealand Journal of Psychiatry, 49(8), 714-723.
DOI Scopus11 WoS8 Europe PMC11
2015 Cairney, I., Galletly, C., de Crespigny, C., Liu, D., Moss, J., & Procter, N. (2015). Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide. Australasian Psychiatry, 23(3), 233-235.
DOI Scopus3 WoS3 Europe PMC3
2015 Posselt, M., Procter, N., Galletly, C., & de Crespigny, C. (2015). Aetiology of coexisting mental health and alcohol and other drug disorders: perspectives of refugee youth and service providers. Australian Psychologist, 50(2), 130-140.
DOI Scopus30 WoS29
2015 Galletly, C. (2015). Let there be light .... Australian and New Zealand Journal of Psychiatry, 49(3), 201-202.
DOI
2015 Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2015). Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study. The Lancet Psychiatry, 2(12), 1092-1098.
DOI Scopus28 WoS25 Europe PMC17
2015 Galletly, C. A. (2015). Making things better?. Australian and New Zealand Journal of Psychiatry, 49(11), 958-959.
DOI
2015 Galletly, C., Clarke, P., Carnell, B., & Gill, S. (2015). A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on. Australian and New Zealand Journal of Psychiatry, 49(11), 1040-1047.
DOI Scopus18 WoS13 Europe PMC9
2015 Badcock, J., Shah, S., Mackinnon, A., Stain, H., Galletly, C., Jablensky, J., & Morgan, V. (2015). Loneliness in psychotic disorders and its association with cognitive function and symptom profile. Schizophrenia Research, 169(1-3), 268-273.
DOI Scopus133 WoS123 Europe PMC104
2015 Galletly, C. A. (2015). ANZJP Weltanschauung. Australian and New Zealand Journal of Psychiatry, 49(8), 677-678.
DOI
2015 de Crespigny, C., Groenkjaer, M., Liu, D., Moss, J., Cairney, I., Procter, N., . . . Galletly, C. (2015). Service provider barriers to treatment and care for people with mental health and alcohol and other drug comorbidity in a metropolitan region of South Australia. Advances in Dual Diagnosis, 8(3), 120-128.
DOI Scopus15 WoS16
2015 Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Psychosis, socioeconomic disadvantage, and health service use in South Australia: Findings from the second. Frontiers in Public Health, 3, 1-8.
DOI Scopus29 Europe PMC22
2015 Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis. Frontiers in Psychology, 6(NOV), 1768-1-1768-8.
DOI Scopus43 WoS40 Europe PMC33
2014 Gill, S., Clarke, P., Rigby, A., Carnell, B., & Galletly, C. (2014). Transcranial Magnetic Stimulation and psychological therapies: Considering the benefits of a combined treatment approach for depression. World Journal of Medical Research, 3(7), 46-53.
2014 Galletly, C. A. (2014). Educating psychiatrists in the post-pharma era. Andhra Pradesh Journal of Psychological Medicine, 15(1), 10-12.
2014 Shah, S., Mackinnon, A., Galletly, C., Carr, V., McGrath, J., Stain, H., . . . Morgan, V. (2014). Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian national survey of psychosis. Schizophrenia Research, 159(1), 20-26.
DOI Scopus30 WoS29 Europe PMC26
2014 Morgan, V., McGrath, J., Jablensky, A., Badcock, J., Waterreus, A., Bush, R., . . . MacKinnon, A. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine, 44(10), 2163-2176.
DOI Scopus162 WoS164 Europe PMC122
2014 Hahn, L., Galletly, C., Foley, D., Mackinnon, A., Watts, G., Castle, D., . . . Morgan, V. (2014). Inadequate fruit and vegetable intake in people with psychosis. Australian and New Zealand Journal of Psychiatry, 48(11), 1025-1035.
DOI Scopus41 WoS40 Europe PMC34
2014 Chan, W., Batterham, P., Christensen, H., & Galletly, C. (2014). Suicide literacy, suicide stigma and help-seeking intentions in Australian medical students. Australasian Psychiatry, 22(2), 132-139.
DOI Scopus90 WoS85 Europe PMC69
2014 Balzan, R. P., Neaves, A., Denson, L. A., Liu, D., & Galletly, C. (2014). Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?. Cognitive Neuropsychiatry, 19(6), 471-484.
DOI Scopus26 WoS26 Europe PMC19
2014 Searle, A., Baghurst, P., van Hooff, M., Sawyer, M., Sim, M., Galletly, C., . . . McFarlane, A. (2014). Tracing the long-term legacy of childhood lead exposure: a review of three decades of the Port Pirie Cohort study. NeuroToxicology, 43, 46-56.
DOI Scopus50 WoS42 Europe PMC33
2014 Foley, D., MacKinnon, A., Morgan, V., Watts, G., McGrath, J., Castle, D., . . . Galletly, C. (2014). Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry, 13(2), 176-183.
DOI Scopus28 WoS29 Europe PMC27
2014 Galletly, C., Clarke, P., Paterson, T., Rigby, A., & Gill, S. (2014). Practical considerations in the use of ultrabrief ECT in clinical practice. Journal of ECT, 30(1), 10-14.
DOI Scopus24 WoS20 Europe PMC14
2014 Posselt, M., Galletly, C., de Crespigny, C., Cairney, I., Moss, J., Liu, D., . . . Banders, A. (2014). Ethics overload: impact of excessive ethical review on comorbidity research. Mental Health and Substance Use, 7(3), 184-194.
DOI Scopus6
2014 Posselt, M., Galletly, C., de Crespigny, C., & Procter, N. (2014). Mental health and drug and alcohol comorbidity in young people of refugee background: a review of the literature. Mental Health and Substance Use, 7(1), 19-30.
DOI Scopus31
2014 Galletly, C. (2014). Should lithium be added to the drinking water?. Australian & New Zealand Journal of Psychiatry, 48(9), 793-794.
DOI
2014 Ashton, M., Rigby, A., & Galletly, C. (2014). Do population-wide tobacco control approaches help smokers with mental illness?. Australian & New Zealand Journal of Psychiatry, 48(2), 121-123.
DOI Scopus14 WoS12 Europe PMC7
2014 Burton, C., Gill, S., Clarke, P., & Galletly, C. (2014). Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Archives of Women's Mental Health, 17(3), 247-250.
DOI Scopus14 WoS13 Europe PMC10
2014 Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2014). Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single module programme. Australian and New Zealand Journal of Psychiatry, 48(12), 1126-1136.
DOI Scopus54 WoS49 Europe PMC37
2014 Hahn, L., Rigby, A., & Galletly, C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Australian and New Zealand Journal of Psychiatry, 48(1), 70-79.
DOI Scopus20 WoS19 Europe PMC18
2013 Galletly, C. (2013). When the body attacks the brain. Australian and New Zealand Journal of Psychiatry, 47(12), 1099-1100.
DOI
2013 Tidswell, J., Kleinig, T., Ash, D., Thompson, P., & Galletly, C. (2013). Early recognition of anti-N-methyl D-aspartate (Nmda) receptor encephalitis presenting as acute psychosis. Australasian Psychiatry, 21(6), 596-599.
DOI Scopus12 WoS10 Europe PMC10
2013 Galletly, C., & Rigby, A. (2013). An overview of cognitive remediation therapy for people with severe mental illness. ISRN Rehabilitation, 2013, 1-6.
DOI
2013 McFarlane, A., Searle, A., Van Hooff, M., Baghurst, P., Sawyer, M., Galletly, C., . . . Clark, L. (2013). Prospective associations between childhood low-level lead exposure and adult mental health problems: The port pirie cohort study. Neurotoxicology, 39, 11-17.
DOI Scopus32 WoS33 Europe PMC22
2013 Galletly, C. (2013). Sunshine, supplements, CBT and more. Australian and New Zealand Journal of Psychiatry, 47(3), 199-200.
DOI
2013 Altree, T., & Galletly, C. (2013). Laxative use and altered drug absorption. Australian and New Zealand Journal of Psychiatry, 47(7), 686.
DOI Scopus3 WoS2 Europe PMC1
2013 Ashton, M., Rigby, A., & Galletly, C. (2013). What do 1000 smokers with mental illness say about their tobacco use?. Australian and New Zealand Journal of Psychiatry, 47(7), 631-636.
DOI Scopus32 WoS30 Europe PMC26
2013 Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Illusory correlations and control across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Journal of Nervous and Mental Disease, 201(4), 319-327.
DOI Scopus25 WoS23 Europe PMC17
2013 Ashton, M., Mulconray, S., Weston, M., Rigby, A., & Galletly, C. (2013). Peer workers' role in smoking-cessation groups for people with mental illness. Australasian Psychiatry, 21(3), 246-248.
DOI Scopus4 WoS6 Europe PMC6
2013 Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Confirmation biases across the psychosis continuum: The contribution of hypersalient evidence-hypothesis matches. British Journal of Clinical Psychology, 52(1), 53-69.
DOI Scopus55 WoS52 Europe PMC39
2013 Ashton, M., Rigby, A., & Galletly, C. (2013). Evaluation of a community-based smoking cessation programme for people with severe mental illness. Tobacco Control, 24(3), 275-280.
DOI Scopus21 WoS20 Europe PMC14
2013 Foley, D., Mackinnon, A., Watts, G., Shaw, J., Magliano, D., Castle, D., . . . Galletly, C. (2013). Cardiometabolic risk Indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One, 8(12), 1-8.
DOI Scopus40 WoS40 Europe PMC35
2012 Hall, T., Galletly, C., Clark, C., Veltmeyer, M., Metzger, L., Gilbertson, M., . . . McFarlane, A. (2012). The relationship between Hippocampal asymmetry and working memory processing in combat-related PTSD: a monozygotic twin study. Biology of Mood & Anxiety Disorders, 2(21), 1-8.
DOI Europe PMC7
2012 Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2012). Evaluating health literacy in people with mental illness using the Test of Functional Health Literacy in Adults. Nursing Outlook, 60(5), 316-321.
DOI Scopus20 WoS19 Europe PMC14
2012 Campbell, L., Hanlon, M., Poon, A., Paolini, S., Stone, M., Galletly, C., . . . Cohen, M. (2012). The experiences of Australian parents with psychosis: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 890-900.
DOI Scopus62 WoS56 Europe PMC35
2012 Stain, H., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 879-889.
DOI Scopus146 WoS136 Europe PMC100
2012 Moore, E., Mancuso, S., Slade, T., Galletly, C., & Castle, D. (2012). The impact of alcohol and illicit drugs on people with psychosis: the Second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 864-878.
DOI Scopus63 WoS57 Europe PMC44
2012 Cooper, J., Mancuso, S., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 851-863.
DOI Scopus143 WoS135 Europe PMC115
2012 Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Reasoning heuristics across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Cognitive Neuropsychiatry, 17(5), 431-450.
DOI Scopus29 WoS28 Europe PMC19
2012 Waterreus, A., Morgan, V., Castle, D., Galletly, C., Jablensky, A., Di Prinzio, P., & Shah, S. (2012). Medication for psychosis - consumption and consequences: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 762-773.
DOI Scopus51 WoS50 Europe PMC46
2012 Galletly, C., Foley, D., Waterreus, A., Watts, G., Castle, D., McGrath, J., . . . Morgan, V. (2012). Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 753-761.
DOI Scopus173 WoS166 Europe PMC137
2012 Waghorn, G., Saha, S., Harvey, C., Morgan, V., Waterreus, A., Bush, R., . . . McGrath, J. (2012). 'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 774-785.
DOI Scopus107 WoS99 Europe PMC74
2012 Morgan, V., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J., Carr, V., . . . Saw, S. (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 735-752.
DOI Scopus422 WoS354 Europe PMC335
2012 Ash, D., Singh, T., Air, T., Burton, C., & Galletly, C. (2012). Metabolic health of people admitted to a psychiatric intensive care unit in Adelaide, South Australia. Primary Care Companion to the Journal of Clinical Psychiatry, 14(1), 1-2.
DOI
2012 Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Over-adjustment or miscomprehension? A re-examination of the jumping to conclusions bias. Australian and New Zealand Journal of Psychiatry, 46(6), 532-540.
DOI Scopus68 WoS69 Europe PMC53
2012 Balzan, R., Delfabbro, P., & Galletly, C. (2012). Delusion-proneness or miscomprehension? A re-examination of the jumping-to-conclusions bias. Australian Journal of Psychology, 64(2), 100-107.
DOI Scopus22 WoS24
2012 Kelly, D., Gill, S., Clarke, P., Burton, C., & Galletly, C. (2012). Delayed response to repetitive transcranial magnetic stimulation treatment for intractable auditory hallucinations in schizoaffective disorder. Annals of Clinical Psychiatry, 24(2), 172-173.
DOI Scopus3 WoS1 Europe PMC1
2012 Forbes, F., Galletly, C., Liu, D., Tyllis, P., & Clark, C. (2012). Assessing cognition in schizophrenia: a comparison of clinician and computerized test administration. Applied Neuropsychology, 19(0001), 9-15.
DOI Scopus4 WoS3 Europe PMC3
2012 Galletly, C., Paterson, T., & Burton, C. (2012). A report on the introduction of ultrabrief pulse width ECT in a private psychiatric hospital. Journal of ECT, 28(1), 59.
DOI Scopus12 WoS10 Europe PMC4
2012 Galletly, C., Gill, S., Clarke, P., Burton, C., & Fitzgerald, P. (2012). A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments?. Psychological Medicine, 42(5), 981-988.
DOI Scopus44 WoS40 Europe PMC37
2012 Galletly, C. (2012). Debates, disputes, discussions and deliberations. Australian and New Zealand Journal of Psychiatry, 46(10), 917-918.
DOI
2012 Dawson, S., Kettler, L., Burton, C., & Galletly, C. (2012). Do people with schizophrenia lack emotional intelligence?. Schizophrenia Research and Treatment, Online, 1-8.
DOI WoS16 Europe PMC11
2012 Silverstein, S., All, S., Thompson, J., Williams, L., Whitford, T., Nagy, M., . . . Gordon, E. (2012). Absolute level of gamma synchrony is increased in first-episode schizophrenia during face processing. Journal of Experimental Psychopathology, 3(4), 702-723.
DOI Scopus5 WoS5
2012 Galletly, C. (2012). People living with psychosis: the good news and the bad news. Australian and New Zealand Journal of Psychiatry, 46(9), 803-807.
DOI Scopus6 WoS4 Europe PMC4
2012 Galletly, C., Clark, L., Van Hooff, M., & McFarlane, A. (2012). CHILDHOOD TRAUMA AND SUBCLINICAL PSYCHOTIC EXPERIENCES IN YOUNG ADULTHOOD: 20-YEAR LONGITUDINAL ANALYSES OF TWO COHORT STUDIES. SCHIZOPHRENIA RESEARCH, 136, S63-S64.
DOI WoS1
2012 Galletly, C. A., de Crespigny, C., Athanasos, P., Moss, J., Proctor, N., Banders, A., . . . Francis, H. (2012). COMORBIDITY ACTION RESEARCH IN NORTHERN ADELAIDE, SOUTH AUSTRALIA. SCHIZOPHRENIA RESEARCH, 136, S276.
DOI
2012 Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G. F., Castle, D., McGrath, J., . . . Morgan, V. A. (2012). HIGH RATES OF CARDIOMETABOLIC RISK FACTORS IN PEOPLE WITH PSYCHOTIC DISORDERS. SCHIZOPHRENIA RESEARCH, 136, S308.
DOI
2011 Galletly, C. A. (2011). Differential diagnosis of Tardive Dyskinesia in an elderly woman taking antipsychotic medication. Annals of Clinical Psychiatry, 23(4), 308-309.
2011 Galletly, C., Van Hooff, M., & McFarlane, A. (2011). PSYCHOTIC SYMPTOMS IN YOUNG ADULTS EXPOSED TO BUSHFIRES DURING CHILDHOOD - A 20 YEAR FOLLOW-UP STUDY. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 45, A34.
2011 Galletly, C., Van Hooff, M., & McFarlane, A. (2011). Psychotic symptoms in young adults exposed to childhood trauma - A 20 year follow-up study. Schizophrenia Research, 127(1-3), 76-82.
DOI Scopus54 WoS54 Europe PMC41
2011 Galletly, C., Bell, S., Burton, C., & Turnbull, C. (2011). Bed accessibility in a private psychiatric hospital. Australasian Psychiatry, 19(2), 160-162.
DOI Scopus2 WoS2
2011 Galletly, C., & Burton, C. (2011). Improving medical student attitudes towards people with schizophrenia. Australian and New Zealand Journal of Psychiatry, 45(6), 473-476.
DOI Scopus57 WoS54 Europe PMC35
2011 Galletly, C. (2011). ANZJP This Month. Australian and New Zealand Journal of Psychiatry, 45(12), 1015-1016.
DOI
2011 Crismani, C., & Galletly, C. (2011). 'Walk-ins': Developing a nursing role to manage unscheduled presentations to a community mental health clinic. Contemporary Nurse, 39(1), 12-19.
DOI Scopus2 WoS2 Europe PMC1
2011 Galletly, C., & Crichton, J. (2011). Accomplishments of the thought disordered person: A case study in psychiatrist-patient interaction. Medical Hypotheses, 77(5), 900-904.
DOI Scopus4 WoS3 Europe PMC1
2010 Singh, R., Rowan, J., Burton, C., & Galletly, C. (2010). How effective is a hospital at home service for people with acute mental illness?. Australasian Psychiatry, 18(6), 512-516.
DOI Scopus12 WoS15 Europe PMC8
2010 Galletly, C., Fitzgerald, P., Clarke, P., Gill, S., Burton, C., & Turnbull, C. (2010). A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service. Australasian Psychiatry, 18(4), 314-317.
DOI Scopus8 WoS8 Europe PMC7
2010 Galletly, C. A. (2010). Ask patients about their internet use. Medical Journal of Australia, 193(5), 312.
DOI Scopus2 WoS1 Europe PMC1
2009 Ash, D., & Galletly, C. (2009). Challenges in psychiatric classification: The case of generalized anxiety disorder. Australasian Psychiatry, 17(6), 484-487.
DOI Scopus1
2009 Galletly, C., Chur-Hansen, A., Air, T., & Chapman, I. (2009). Academics of the future? A survey of final year medical students. Australasian Psychiatry, 17(6), 502-505.
DOI Scopus10 WoS9 Europe PMC9
2009 Harvey, K., Galletly, C., Field, C., & Proeve, M. (2009). The effects of verbalisation on cognitive performance in schizophrenia: A pilot study using tasks from Delis Kaplan Executive Function System. Neuropsychological Rehabilitation, 19(5), 733-741.
DOI Scopus12 WoS10 Europe PMC7
2009 Alexander, D., Flynn, G., Wong, W., Whitford, T., Harris, A., Galletly, C., & Silverstein, S. (2009). Spatio-temporal EEG waves in first episode schizophrenia. Clinical Neurophysiology, 120(9), 1667-1682.
DOI Scopus27 WoS27 Europe PMC26
2009 Clark, C., Galletly, C., Ash, D., Moores, K., Penrose, R., & McFarlane, A. (2009). Evidence-based medicine evaluation of electrophysiological studies of the anxiety disorders. Clinical EEG and Neuroscience, 40(2), 84-112.
DOI Scopus58 WoS46 Europe PMC38
2009 Galletly, C. (2009). Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology, 202(1-3), 259-273.
DOI Scopus43 WoS30 Europe PMC27
2009 Galletly, C., & Burton, C. (2009). The effects of experiencing simulated auditory hallucinations on attitudes to schizophrenia in final year medical students. Proceedings of 2nd Biennial Schizophrenia International Research Conference, 117(2-3), 402-403.
DOI WoS1
2008 Flynn, G., Alexander, D., Harris, A., Whitford, T., Wong, W., Galletly, C., . . . Williams, L. (2008). Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophrenia Research, 105(1-3), 262-271.
DOI Scopus63 WoS59 Europe PMC50
2008 Nestor, P., & Galletly, C. (2008). The employment of consumers in mental health services: politically correct tokenism or genuinely useful?. Australasian Psychiatry, 16(5), 344-347.
DOI Scopus29 WoS28 Europe PMC20
2008 Savilla, K., Kettler, L., & Galletly, C. (2008). Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Australian and New Zealand Journal of Psychiatry, 42(6), 496-504.
DOI Scopus99 WoS85 Europe PMC73
2008 Galletly, C., McFarlane, A., & Clark, C. (2008). Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder. Psychiatry Research, 159(1-2), 196-206.
DOI Scopus9 WoS9 Europe PMC10
2008 Williams, L., Whitford, T., Flynn, G., Wong, W., Liddell, B., Silverstein, S., . . . Gordon, E. (2008). General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro, test battery. Schizophrenia Research, 99(1-3), 182-191.
DOI Scopus97 WoS82 Europe PMC67
2008 Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Does antenatal screening for psychosocial risk factors predict postnatal depression? A follow-up study of 154 women in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 51-55.
DOI Scopus47 WoS42 Europe PMC37
2008 Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Antenatal psychosocial risk factors and depression amoung women living in socioeconomically disadvantaged suburbs in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 45-50.
DOI Scopus53 WoS47 Europe PMC43
2008 Keks, N., Galletly, C. A., Hope, J., & Hustig, H. (2008). Management of acute psychosis in an emergency setting. Advances in Schizophrenia and Clinical Psychiatry, 3, 78`-83.
2007 Galletly, C. A., McFarlane, A. C., & Clark, C. R. (2007). Erratum to "Impaired updating of working memory in schizophrenia" [International Journal of Psychophysiology 63 (2007) 265-274] (DOI:10.1016/j.ijpsycho.2006.11.004). International Journal of Psychophysiology, 66(3), 271.
DOI
2007 Plevin, D., Galletly, C., & Roughan, P. (2007). Sexual dysfunction in men treated with depot antipsychotic drugs: A pilot study. Sexual Health, 4(4), 269-271.
DOI Scopus6 WoS7 Europe PMC3
2007 Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007). Psychological benefits of a high-protein low-carbohydrate diet in obese women with polycystic ovary syndrome - A pilot study. Appetite, 49(3), 590-593.
DOI Scopus82 WoS71 Europe PMC63
2007 Galletly, C., McFarlane, A., & Clark, C. (2007). Impaired updating of working memory in schizophrenia. International Journal of Psychophysiology, 63(3), 265-274.
DOI Scopus28 WoS24 Europe PMC18
2006 Galletly, C., & Watson, D. (2006). Substance misuse in patients with acute mental illness. Medical Journal of Australia, 184(12), 645.
DOI Scopus1 WoS1 Europe PMC1
2006 Brown, K., Alexander, D., Boord, P., Das, P., Flynn, G., Galletly, C., . . . Williams, L. (2006). Reduced fMRI activity in response to salient stimuli in first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 279-280.
DOI
2006 Galletly, C., Proeve, M., Field, C., & Harvey, K. (2006). Silence is golden? Improving cognitive performance in schizophrenia.. Acta neuropsychiatrica, 18(6), 251.
DOI
2006 Das, P., Alexander, D., Boord, P., Brown, K., Flynn, G., Galletly, C., . . . Wong, W. (2006). Impaired connectivity in amygdala pathways may explain disorganization symptoms of patients with first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 282.
DOI Europe PMC1
2006 Alexander, D., Boord, P., Brown, K., Das, P., Flynn, G., Galletly, C., . . . Wong, W. (2006). First-episode psychosis and direction of wave propagation at 1 Hz in the EEG.. Acta neuropsychiatrica, 18(6), 240.
DOI Europe PMC1
2005 Galletly, C., Clark, C., & McFarlane, A. (2005). Clozapine improves working memory updating in schizophrenia. European Neuropsychopharmacology, 15(6), 601-608.
DOI Scopus16 WoS15 Europe PMC13
2004 Galletly, C. (2004). Crossing professional boundaries in medicine: the slippery slope to patient sexual exploitation. Medical Journal of Australia, 181(7), 380-383.
DOI Scopus55 WoS44 Europe PMC24
2004 Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2004). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Journal of Clinical Endocrinology and Metabolism, 89(7), 3337-3344.
DOI Scopus150 WoS121 Europe PMC99
2004 Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., Galletly, C., & Norman, R. J. (2004). Erratum: Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome (Journal of Clinical Endocrinology and Metabolism (2003) 88 (812-819)). Journal of Clinical Endocrinology and Metabolism, 89(5), 2337.
2003 Ash, D., Galletly, C., Haynes, J., & Braben, P. (2003). Violence, self-harm, victimisation and homelessness in patients admitted to an acute inpatient unit in South Australia. International Journal of Social Psychiatry, 49(2), 112-118.
DOI Scopus19 Europe PMC14
2003 Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2003). Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(2), 812-819.
DOI Scopus444 WoS357 Europe PMC283
2001 Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2001). Working memory in posttraumatic stress disorder - An event-related potential study. Journal of Traumatic Stress, 14(2), 295-309.
DOI Scopus71 WoS62 Europe PMC55
2000 Comley, C., Galletly, C., & Ash, D. (2000). The use of atropine eye drops for clozapine induced hypersalivation. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034.
DOI
2000 Galletly, C. (2000). Psychiatry and fertility services. Australasian Psychiatry, 8(3), 264-266.
2000 Galletly, C., Clark, C., & McFarlane, A. (2000). Treating cognitive dysfunction in patients with schizophrenia. Journal of Psychiatry & Neuroscience, 25(2), 117-124.
Scopus19 WoS19 Europe PMC14
2000 Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (2000). The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Progress in Neuro Psychopharmacology and Biological Psychiatry, 24(8), 1329-1338.
DOI Scopus26 WoS24 Europe PMC16
2000 Galletly, C. (2000). Correspondence. Australasian Psychiatry, 8(3), 264-265.
DOI
2000 Comley, C., Galletly, C., & Ash, D. (2000). Use of atropine eye drops for clozapine induced hypersalivation [5]. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034.
DOI Scopus43 Europe PMC29
1999 Galletly, C. (1999). Prescribing of psychotropic drugs in an acute inpatient unit. Australian and New Zealand Journal of Psychiatry, 33(2), 181-182.
DOI Scopus5 Europe PMC3
1999 Galletly, C., Clark, C., McFarlane, A., & Weber, D. (1999). Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia. Psychiatric Services, 50(1), 101-103.
DOI Scopus16 WoS13 Europe PMC12
1999 Ash, D., Galletly, C., Kinneally, J., & Braben, P. (1999). Self-Reported Forensic Histories Among Patients Admitted to an Acute Psychiatric Unit. Psychiatry, Psychology and Law, 6(2), 197-202.
DOI Scopus1
1998 Clark, A., Thornley, B., Tomlinson, L., Galletly, C., & Norman, R. (1998). Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction, 13(6), 1502-1505.
DOI Scopus624 WoS489 Europe PMC360
1998 Galletly, C., & Whyte, F. (1998). Epidemiology of prostate cancer in two European countries: Scotland and Norway. European Journal of Cancer Care, 7(4), 240-246.
DOI
1997 Galletly, C. (1997). Borderline-dissociation comorbidity [8]. American Journal of Psychiatry, 154(11), 1629.
DOI Scopus7 Europe PMC2
1997 Galletly, C. A., & Tsourtos, G. (1997). Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80.
DOI Scopus12 Europe PMC9
1997 Galletly, C. A. (1997). Dissociation and PTSD. American Journal of Psychiatry, 154, 1629.
1997 Field, C., Galletly, C., Anderson, D., & Walker, P. (1997). Computer aided cognitive rehabilitation possible application to the attentional deficit of schizophrenia, a report of negative results. Perceptual and Motor Skills, 85(3, part 1), 995-1002.
DOI Scopus32 Europe PMC18
1997 Galletly, C., Clark, R., McFarlane, A., & Lueber, D. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine.. Psychiatry Research, 72, 159-161.
1997 Galletly, C. (1997). Clinical rating scales for substance abuse. Psychiatric Services, 48(1), 105-106.
DOI
1997 Galletly, C., & Tsourtos, G. (1997). Antipsychotic drug doses in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80.
DOI
1997 Galletly, C. (1997). Borderline-Dissociation Comorbidity. American Journal of Psychiatry, 154, 629.
1997 Ash, D., & Galletly, C. (1997). Crisis beds: The interface between the hospital and the community. International Journal of Social Psychiatry, 43(3), 193-198.
DOI Scopus8 Europe PMC5
1997 Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Research, 72(3), 161-166.
DOI Scopus108 WoS91 Europe PMC69
1996 Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders. BRITISH JOURNAL OF PSYCHIATRY, 169(6), 793-794.
DOI WoS1 Europe PMC1
1996 118. McFarlane, A. C., Clark, C. R., Weber, D., & Galletly, C. A. (1996). Biological paradigms of the attentional processing in post traumatic stress disorder. European Neuropsychopharmacology, 6, 80.
1996 Galletly, C., Clark, A., & Tomlinson, L. (1996). Evaluation of dexfenfluramine in a weight loss program for obese infertile women.. International Journal of Eating Disorders, 19(2), 209-212.
DOI Scopus11 Europe PMC6
1996 Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). Improved pregnancy rates for obese, infertile women following a group treatment program: an open pilot study. General Hospital Psychiatry, 18(3), 192-195.
DOI Scopus50 Europe PMC23
1996 Galletly, C. (1996). Comment on "Sexual Abuse in therapy : gender issues.". Australian and New Zealand Journal of Psychiatry, 30, 132-133.
1996 Galletly, C. (1996). Subjective muscle weakness and hypotnoia during Clozapine treatment. Annals of Clinical Psychiatry, 8(4), 189-192.
DOI Scopus6 Europe PMC6
1996 Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). A group program for obese, infertile women: weight loss and improved psychological health. Journal of Psychosomatic Obstetrics and Gynaecology, 17(2), 125-128.
DOI Scopus38 Europe PMC23
1996 Galletly, C., Clark, C., & McFarlane, A. (1996). Artificial Neural Networks: A prospective tool for the analysis of psychiatric disorders.. Journal of Psychiatry and Neuroscience, 21(4), 239-247.
Scopus14 WoS10 Europe PMC5
1996 Galletly, C., Wilson, D., & McEwen, S. (1996). Eosiniphilia associated with decreasing neutrophil count in a Clozapine-treated patient.. Journal of Clinical Psychiatry, 57, 40-41.
Scopus4 Europe PMC23
1996 Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders.. British Journal of Psychiatry the Journal of Mental Science, 169(6), 793-794.
DOI Scopus1
1996 Galletly, C. (1996). Comment. Australian and New Zealand Journal of Psychiatry, 30(1), 132-133.
DOI
1995 Clark, A., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. (1995). Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction, 10(10), 2705-2712.
DOI Scopus553 WoS400 Europe PMC292
1995 Galletly, C. A., Schrader, G. D., Chestemtan, H. M., & Tsourtos, G. (1995). Medical student attitudes to psychiatry: lack of effect of psychiatric hospital experience. Medical Education, 29(6), 449-451.
DOI Scopus44 WoS34 Europe PMC20
1993 123. Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, R. (1993). A review of the efficacy of low-dose antipsychotic medication in the treatment of schizophrenia. Schizophrenia Bulletin, 19, 155-164.
1993 Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, C. R. (1993). Low-dose depot medication in schizophrenia. Schizophrenia Bulletin, 19(1), 155-164.
DOI Scopus15 WoS17 Europe PMC7
1993 Galletly, C. A. (1993). Psychiatrist-patient sexual relationships: The ethical dilemmas. Australasian Psychiatry, 27(1), 133-139.
DOI Scopus17 WoS14 Europe PMC11
1993 Galletly, C. A., Field, C. D., & Prior, M. (1993). Urine drug screening of patients admitted to a state psychiatric hospital. Hospital and Community Psychiatry, 44(6), 587-589.
DOI Scopus28 WoS25 Europe PMC15
1992 Galletly, C. A. (1992). Antipsychotic drug doses in a schizophrenia inpatient unit. Australian and New Zealand Journal of Psychiatry, 26(4), 574-576.
DOI Scopus17 WoS15 Europe PMC8
1991 Galletly, C. A., Field, C. D., & Ormond, C. L. (1991). Changing patterns of electroconvulsive therapy use: Results of a five-year survey. Australian and New Zealand Journal of Psychiatry, 25(4), 535-540.
DOI Scopus9 WoS9 Europe PMC7
1991 Galletly, C. A. (1991). A review of antipsychotic drug doses.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 11, 74-76.
1987 Galletly, C. A., Field, C., & Ormond, C. (1987). An audit of electroconvulsive therapy.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 7(27), 171-174.
Scopus1 Europe PMC1
1987 Galletly, C. A., & Field, C. D. (1987). Learning and memory impairment with benzhexol. Australian and New Zealand Journal of Psychiatry, 21(4), 612-614.
DOI Scopus4 WoS5 Europe PMC2
1985 Galletly, C. A., Morris, H., & Newcombe, A. (1985). The dexamethasone suppression test in elderly, non-depressed patients with dementia. Australian and New Zealand Journal of Psychiatry, 19(1), 95-96.
DOI Scopus3 WoS2 Europe PMC3
1983 131. Morris, H. A., Gilliland, J. M., Berriman, H. E., & Galletly, C. A. (1983). Assessment of the dexamethasone suppression test of endogenous depression. Clinical Biochemical Research, 4, 82.
1982 Manley, D., & Galletly, C. A. (1982). Survey of children and their families presenting at a child psychiatric service. New Zealand Medical Journal, 95(718), 732-734.
1982 James, B., & Galletly, C. A. (1982). The psychiatric contribution to general medical education: Some problems of generalization. Medical Education, 16(3), 147-150.
DOI Scopus1 Europe PMC1
1979 Franzcp, B. J., & Galletly, C. A. (1979). Case notes as indicators of the prevailing medical model: Implications. New Zealand Medical Journal, 90(648), 427-431.
1979 Galletly, C., & James, B. (1979). Anorexia nervosa in a male: Comment and illustration. New Zealand Medical Journal, 89(631), 171-173.
Scopus2 Europe PMC1
- Galletly, C. (2014). Role of cognitive enhancement in schizophrenia. Neuroscience and Neuroeconomics, 75.
DOI

Year Citation
2019 Galletly, C., & McFarlane, A. S. (2019). Memory disturbances in schizophrenia and posttraumatic stress disorder. In A. Moskowitz, I. Schäfer, & M. Dorahy (Eds.), Psychosis, Trauma and Dissociation: Evolving Perspectives on Severe Psychopathology (2nd revised ed., pp. 271-282). NJ; USA: John Wiley & Sons.
DOI
2016 Ashton, M., Carnell, B. L., & Galletly, C. (2016). Smokers with Severe Mental Illness. In V. R. Preedy (Ed.), Neuropathology of Drug Addictions and Substance Misuse (Vol. 1, pp. 254-259). London; United Kingdom: Academic Press.
DOI
2013 Galletly, C., Lincoln, A., & Arford, T. (2013). Health literacy and people with mental illness. In R. Moore, & D. Perry (Eds.), Health Literacy: Developments, Issues and Outcomes (1 ed., pp. 143-158). United States: Nova Science Publishers.
2008 Galletly, C. A. (2008). Working Memory in Schizophrenia. In N. Johansen (Ed.), New Research on Short Term Memory. Hauppauge. New York: Nova Science Publishers.

Year Citation
2019 Weickert, T., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W., . . . Weickert, C. S. (2019). REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION. In SCHIZOPHRENIA BULLETIN Vol. 45 (pp. S318). Orlando, FL: OXFORD UNIV PRESS.
DOI WoS6
2018 Balzan, R., Delfabbro, P., Galletly, C., Mattiske, J., & McLean, B. (2018). Metacognitive Therapy (MCT plus ) for psychosis. In AUSTRALIAN PSYCHOLOGIST Vol. 53 (pp. 5). WILEY.
2018 Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Nga, T. (2018). THE ROYAL AUSTRALIAN AND NEW ZEALAND CLINICAL PRACTICE GUIDELINES FOR SCHIZOPHRENIA AND RELATED DISORDERS (2016) - A STEP TOWARDS BETTER CARE?. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S214). Florence, ITALY: OXFORD UNIV PRESS.
DOI WoS2
2018 Wong, K. T. G., King, D., Balzan, R., Liu, D., & Galletly, C. (2018). TECHNOLOGY LITERACY AND ENGAGEMENT IN PEOPLE WITH SCHIZOPHRENIA. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S208). Florence, ITALY: OXFORD UNIV PRESS.
DOI WoS1
2018 Weickert, T., Cai, H., O'Donnell, M., Balzan, R., Wells, R., Liu, D., . . . Weickert, C. S. (2018). ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S73-S74). Florence, ITALY: OXFORD UNIV PRESS.
DOI WoS2
2018 Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2018). HEALTH LITERACY IN PEOPLE WITH SCHIZOPHRENIA ATTENDING COMMUNITY MENTAL HEALTH CLINICS. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S137). Florence, ITALY: OXFORD UNIV PRESS.
DOI WoS1
2016 Myles, H., Antic, N. A., Adams, R., Chandratilleke, M., Liu, D., Myles, N., . . . Galletly, C. (2016). CLOZAPINE: THE DOUBLE-EDGED SWORD - A WORKSHOP ON THE QUALITY AND SAFE USE OF CLOZAPINE. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 50 (pp. 17). SAGE PUBLICATIONS LTD.
2014 Morgan, V. A., Badcock, J., Waterreus, A., Galletly, C., Shah, S., & Mackinnon, A. (2014). THE ROLE OF COGNITION IN METABOLIC DISTURBANCE IN PEOPLE WITH PSYCHOTIC ILLNESS: NOVEL DATA FROM A LARGE POPULATION PREVALENCE SURVEY. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S223-S224). ELSEVIER SCIENCE BV.
DOI
2014 Galletly, C., Hahn, L., Foley, D., McKinnon, A., Watts, G., Castle, D., . . . Morgan, V. A. (2014). DETERMINANTS OF POOR DIET AMONG A LARGE SAMPLE OF PEOPLE LIVING WITH A PSYCHOTIC ILLNESS. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S316). ELSEVIER SCIENCE BV.
DOI
2014 Galletly, C., Lincoln, A., Burton, C., Arford, T., Prener, C., & Liu, D. (2014). LIMITED LITERACY AMONG PEOPLE WITH SERIOUS MENTAL ILLNESS IN THE US AND AUSTRALIA: A NATURAL EXPERIMENT?. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S121-S122). ELSEVIER SCIENCE BV.
DOI
2014 Galletly, C., Foley, D. L., Mackinnon, A., Watts, G. F., Shaw, J., Magliano, D., . . . Morgan, V. A. (2014). RISK FACTORS FOR DEATH AND DISABILITY IN YOUNG PEOPLE WITH PSYCHOSIS. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S19-S20). ELSEVIER SCIENCE BV.
DOI
2014 Waterreus, A., Di Prinzio, P., Galletly, C., Castle, D. J., Watts, G., & Morgan, V. A. (2014). METABOLIC SYNDROME IN PEOPLE WITH PSYCHOSIS: IS CANNABIS PROTECTIVE?. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S381). ELSEVIER SCIENCE BV.
DOI
2010 Balzan, R., Delfabbro, P., & Galletly, C. (2010). HOW HYPOTHESIS-CONFIRMING AND HYPOTHESIS-DISCONFIRMING INFORMATION IS TREATED ACROSS THE PSYCHOSIS CONTINUUM. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 44 (pp. A35). INFORMA HEALTHCARE.
2010 Galletly, C., Silverstein, S., Huby, A., Williams, L., & Harris, A. (2010). COGNITION IN RECENT ONSET SCHIZOPHRENIA. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 44 (pp. A41). INFORMA HEALTHCARE.
2010 Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2010). Health literacy in schizophrenia and depression. In Proceedings of 11th Australasian schizophrenia conference 2010 Vol. 44 (pp. 0 pages). INFORMA HEALTHCARE.
DOI
2009 Galletly, C., Clarke, L., Legg, J., James, L., Connor, J., & Air, T. (2009). Assessing the quality of the first episode psychosis services in Adelaide. In ANZ Journal of Psychiatry (pp. 27).
2009 Clark, L., Galletly, C., Legg, L., James, L., Connor, J., & Air, T. (2009). Substance Use in Young People with First Episode Psychosis in Adelaide. In Australian & New Zealand Journal of Psychiatry Vol. 43 (pp. 0 pages). UK: You need to add a publisher.
DOI
2009 Clarke, P., Gill, S., & Galletly, C. (2009). PRELIMINARY REPORT COMPARING TRANSCRANIAL MAGNETIC STIMULATION DELIVERED THREE TIMES PER WEEK VERSUS FIVE TIMES PER WEEK. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 43 (pp. A5). SAGE PUBLICATIONS LTD.
2009 Galletly, C. (2009). SCHIZOPHRENIA SYMPOSIUM RECENT RESEARCH IN SCHIZOPHRENIA - WHAT DO WE REALLY KNOW?. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 43 (pp. A9). SAGE PUBLICATIONS LTD.
2005 Edwards, B., Semmler-Booth, T., Galletly, C., & Dekker, G. (2005). Detecting risk for depression at first antenatal visit. In Australian and New Zealand Journal of Psychiatry Vol. 39 (pp. A113-A114). Blackwell Publishing Asia.
DOI
2004 Galletly, C. A., McFarlane, A., & Clark, R. (2004). Clozapine improves cerebral indices of working memory function in schizophrenia. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY Vol. 7 (pp. S403). Paris, FRANCE: CAMBRIDGE UNIV PRESS.
2003 Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2003). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.. In Asia Pacific journal of clinical nutrition Vol. 12 Suppl (pp. S52). Australia.
Europe PMC2
2000 Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2000). The effects of treatment with Clozapine on ERP indices of working memory in schizophrenia. In Sidney Bloch (Ed.), Abstracts for the 35th Annual Congress - Looking Outward: Culture, Creativity & Psychiatry Vol. 34 (pp. A25). Victoria, Australia: Blackwell Science Asia.
DOI

Year Citation
2023 Schubert, K. O., Pathirana, M., FUGARO, P., Onf, H., Fenech, D., GUIDOLIN, M., . . . Wright, S. (2023). EXTERNAL AND SERVICE FACTORS INFLUENCING OUTCOMES IN A MODEL OF STRATIFIED MENTAL HEALTH SERVICES FOR YOUNG PEOPLE. Poster session presented at the meeting of International Conference on Early Intervention 14. Luscerne, Switzerland.
2022 Clark, S., Mills, N., Toben, C., Catharine, J., & Galletly, C. (2022). Evaluating Technological Solutions To Mental Health Teaching And Assessment During The Pandemic. Poster session presented at the meeting of Australian and New Zealand College of Psychiatrists Congress 2022. Australian and New Zealand Journal of Psychiatry.
2022 Falk, A. J., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2022). BEYOND NEURORECEPTOR AUTOIMMUNITY: PERIPHERAL AUTOANTIBODY PROFILES ARE ASSOCIATED WITH CLINICAL FEATURES IN PSYCHOTIC DISORDERS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. Sydney, NSW: SAGE PUBLICATIONS LTD.
2019 Lee, C., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Poster session presented at the meeting of Biological Psychiatry. Chicago, IL: Elsevier B.V..
DOI
2019 Weickert, T., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W., . . . Weickert, C. S. (2019). Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation. Poster session presented at the meeting of BIOLOGICAL PSYCHIATRY. Chicago, IL: ELSEVIER SCIENCE INC.
DOI
2018 Galletly, C., Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., . . . Wittert, G. (2018). OBSTRUCTIVE SLEEP APNOEA IS COMMON IN SCHIZOPHRENIA AND RESPONDS WELL TO TREATMENT - A NOVEL AND PRACTICAL MEANS TO IMPROVE COGNITION AND METABOLIC HEALTH?. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. Florence, ITALY: OXFORD UNIV PRESS.
DOI
2018 Galletley, C., Ash, D., Sweeney, S., & Crichton, J. (2018). Conversing with people with thought disorder. Poster session presented at the meeting of Schizophrenia bulletin. UK: Oxford University Press.
DOI
2017 Galletly, C., Gill, S., Clarke, P., Paterson, T., & Hahn, L. (2017). Attracting good rTMS habits: a workshop in the practical and clinical application of RTMS in psychiatry. Poster session presented at the meeting of RANZCP Abstracts. Adelaide, S.A.: Sage.
DOI
2017 Galletly, C., Gill, S., Clarke, P., Paterson, T., & Hahn, L. (2017). Attracting good rTMS habits: a workshop in the practical and clinical application of RTMS in psychiatry. Poster session presented at the meeting of RANZCP Abstracts. Adelaide, S.A.: Sage.
DOI
2017 Weickert, T., Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., Liu, D., . . . Weickert, C. S. (2017). C-Reactive Protein as a Marker of Inflammation in Acute Psychosis and Schizophrenia. Poster session presented at the meeting of Abstracts, as published in Biological Psychiatry. San Diego, CA: ELSEVIER SCIENCE INC.
DOI WoS1
2017 Weickert, T., Kindler, J., Zavitsanou, K., Lim, C., Guillemin, G., Galletly, C., . . . Weickert, C. S. (2017). Dysregulation of Kynurenine Metabolism is Related to Proinflammatory Cytokines, Prefrontal Cortex Volume, and Attention in Schizophrenia. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. San Diego, CA: OXFORD UNIV PRESS.
DOI WoS1
2017 Burgess, M., Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., . . . Weickert, C. S. (2017). HOW RELIABLE ARE PERIPHERAL BIOMARKERS OF INFLAMMATION IN SCHIZOPHRENIA?. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. San Diego, CA: OXFORD UNIV PRESS.
2014 Foley, D. L., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2014). Best buys for early intervention to improve cardiometabolic health in adults with psychosis: an Australian perspective. Poster session presented at the meeting of EARLY INTERVENTION IN PSYCHIATRY. WILEY-BLACKWELL.
2013 Looi, J. C. L., Kisely, S. R., Galletly, C., Macfarlane, M. D., Power, B. D., & Merry, S. N. (2013). RESEARCH IN THE RANZCP TRAINING PROGRAM. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD.
2013 Galletly, C., Fitzgerald, P., Gill, S., Rigby, A., Loo, C., & Martin, D. (2013). REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) AND DIRECT CURRENT STIMULATION (DCS) TREATMENTS FOR PSYCHIATRIC DISORDERS - AN UPDATE FOR CLINICIANS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD.
2013 Malhi, G., Galletly, C., Hay, P., & Walters, H. (2013). REVIEW OF THE RANZCP CLINICAL PRACTICE GUIDELINES 2013. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD.
2012 Morgan, V. A., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J. J., Carr, V., . . . Saw, S. (2012). NOVEL DATA FROM A LARGE POPULATION PREVALENCE SURVEY: A UNIQUE OPPORTUNITY TO INFORM PSYCHOSIS RESEARCH DIRECTIONS AND MENTAL HEALTH REFORM. Poster session presented at the meeting of SCHIZOPHRENIA RESEARCH. ELSEVIER SCIENCE BV.
DOI WoS1
2012 Stain, H. J., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). THE SOCIAL CONSEQUENCES FOR ADULTS EXPERIENCING PSYCHOSIS: FINDINGS FROM THE SECOND AUSTRALIAN NATIONAL SURVEY OF PSYCHOSIS. Poster session presented at the meeting of SCHIZOPHRENIA RESEARCH. ELSEVIER SCIENCE BV.
DOI
2011 Galletly, C., Holmes, J., Murray, R., & Sachdev, P. (2011). THE BEST IN PSYCHIATRIC RESEARCH. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE.
2011 Brennan, A., Harris, A., Williams, L., Galletly, C., Silverstein, S., Starling, J., & Nagy, M. (2011). SCHIZOPHRENIA AS A DISORDER OF "NEURAL INTEGRATION": LINKING BRAIN SYNCHRONY, COGNITION, EMOTION AND CLINICAL PROFILE. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE.
2011 Galletly, C., Gill, S., Clarke, P., Kelly, D., Mckenny, B., Paterson, T., & Burton, C. (2011). NEUROSTIMULATION SYMPOSIUM. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE.
2011 Burton, C., Neaves, A., Denson, L., & Galletly, C. (2011). FUNCTIONAL HEALTH LITERACY IN PEOPLE WITH MENTAL ILLNESS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE.
2010 Ash, D., Galletly, C., Singh, T., Burton, C., & Air, T. (2010). Metabolic risk factors and weight gain in people admitted to a psychiatric intensive care unit. Poster session presented at the meeting of Proceedings of 2nd Biennial Schizophrenia International Research Conference. Netherlands: Elsevier.
DOI
NHMRC Grants
2021- 2025 A National Research Translation Centre to implement Mental Health Care at Scale NHMRC Special Initiative in Mental Health Grant 2021 CI on ALIVE Led by A/Prof Victoria Palmer. $10,000,000
2020 Australasian Partnership for Improving Outcomes in Severe Depression. NHMRC Partnership Projects, Australia: 1195643 Loo, C., Martin, D., Mitchell, P.B., Hadzi-Pavlovic, D., Chatterton, M.L., Galletly, C., Hopwood, M., Sara, G. $909,752.00
2016-2019 Project Grant; Title: “N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial National Health and Medical Research Council (NHRMC), Australia: 1098442 Castle, D., Rossell, S., Galletly, C., Harris, A., Francies, P., Siskind, D $981,788.85
2016-2020 Project Grant; Title: “An empirical framework for assessing mortality and morbidity in people with psychotic disorders: 7-year prospective and 10-year retrospective follow-up of 2075 participants in the Survey of High Impact Psychosis (SHIP) using linked registers National Health and Medical Research Council (NHRMC), Australia: 1102628 Morgan, V., McGrath, J., Galletly, C., Harvey, C., Castle, D., Cohen, M., Jablensky, A., Carr, V., Neil, A., Wattereus, A $626,179
2011-2012 Grant, Title: “Australian Schizophrenia Research Bank”, (extension) National Health and Medical Research Council (NHRMC), Australia: 386500 Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C., Tooney, P., Rasser, P., Lewin, T., Stain, H,MM Badcock, J., Morgan, V., de Zubicaray, G., Budd, B., Seal, M., Soulsby, B., Velakoulis, D., Kader, L., Kalaydjieva, L., Weickert, T., Galletly, C; Enabling $440,650
2006-2011 Enabling Grant, Title: “Australian Schizophrenia Research Bank” National Health and Medical Research Council (NHRMC), Australia: 386500 Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C., Tooney, P., Rasser, P., Lewin, T., Stain, H,mm Badcock, J., Morgan, V., de Zubicaray, G., Budd, B., Seal, M., Soulsby, B., Velakoulis, D., Kader, L., Kalaydjieva, L., Weickert, T., Galletly, C $1,750,000
2007-2009 Research Grant; Title: “Childhood cognitive antecedents of adult psychopathology: follow up of the Port Pirie lead cohort into adulthood National Health and Medical Research Council (NHMRC), Australia: ID 453563 McFarlane A, Galletly C, Sim M, Sawyer M, Baghurst P $587,263
MRFF
2021-2026 Mental Health Australia General Clinical Trial Network (MAGNET). One of 50 Chief Investigators, working across diverse areas to build MAGNET: the first Australia-wide clinical trials network in adult mental health. Medical Research Future Fund (MRFF) CI on 2020 Million Minds Mission Mental Health Research Grant, Australia: 2006296 led by M Berk. $11,998,907
The Hospital Research Foundation
2020 Establishing and Evaluating a Mental Health Single Entry Point (SEP) to Improve Depression Care for Young People. The Hospital Research Foundation Translational Grant, Adelaide Schubert, O., Galletly, C., Clark, S., Wright, S. $70,000
Commonwealth Department of Health and Ageing
2009-2011 Research Grant; Title: “National Survey of High Impact Psychosis (SHIP) Commonwealth Dept of Health and Ageing, Australia Jablensky A, Bush R , Carr V, Castle D, Galletly C, Harvey C, Hocking B, Mackinnon A , McGorry P, Morgan V, McGrath J, Stain H, Waterreus A, Neil A, Saw S $6,155,514
ARC Linkage Grant
2011-2013 Linkage Grant; Title: “Stopping the run-around: comorbidity action in the north (CAN) Australian Research Council, Australia: LP110100087 de Crespigny CF, Galletly C, Athanasos P, Procter NG, Moss JR, Rowlands CE, Liu DT, Tyllis P, Chong AJ, Lee D $275,820
The Stanley Medical Research Institute (USA)
2013 Canakinumab adjunctive treatment trial to reduce symptoms and improve cognition in patients with schizophrenia displaying elevated peripheral IL-1beta The Stanley Medical Research Institute . Weickert, T.W., Weickert, C.S., Catts, S.V., Lenroot, R., Galletly, C., Wakefield, C., Lloyd A USD $361,132
Course Coordination

2011-2020 - MBBS Year 6 Course Convenor

  • Regular tutorial teaching for Year 6 Program – ‘Early mortality in people with schizophrenia – why?’

2003–2013 - MBBS Year 6 Psychiatry clinical placements (The Adelaide Clinic)

2003–2007 - MBBS Years 4 and 6 Psychiatry clinical placements (LMHS)

2004–2007 - Medical and Scientific attachment, MBBS years 4 and 5

MBBS Committees

2011-2020 - Curriculum Committee

2011-2021 - Assessment Committee

2011-2019 - Scientific Basis of Medicine Committee

Examiner / Assessor

2011-2019 - Board of Examiners, Year 4/5 MBBS

2003-2019 - Board of Examiners, Year 6 MBBS

1996 (ongoing) - Assessor for clinical competence, written and OSCI examinations, various year levels MBBS

Seminar / Tutorial / Lecture Teaching

1996 (ongoing) - Participation in teaching at various year levels MBBS

2005 (ongoing) - Tutorial teaching, year 6, MBBS psychiatry

2010-2019 - Coordinate and teach Tranisition to Internship teaching in psychiatry, Year 6 MBBS

Date Role Research Topic Program Degree Type Student Load Student Name
2014 - 2020 Principal Supervisor Schizophrenia and Obstructive Sleep Apnoea Doctor of Philosophy Doctorate Part Time Dr Hannah Dawn Myles
2013 - 2017 Principal Supervisor Health Risk Factors Associated with Morbidity and Mortality in a National Sample of People with Psychosis Doctor of Philosophy Doctorate Full Time Miss Lisa Anne Hahn
2011 - 2016 Principal Supervisor Brave in their New World: Service Provision for Refugee Youth with Comorbidity in Northern Metropolitan Adelaide Doctor of Philosophy Doctorate Full Time Ms Miriam Tamsin Posselt
2011 - 2015 Co-Supervisor Addressing Aboriginal Community People's Mental Health and Alcohol and Drug Comorbidity Service needs in the Salisbury and Playford Local Government Areas of South Australia Doctor of Philosophy Doctorate Full Time Mrs Hepsibah Sharmil Francis Jebaraj
2010 - 2015 Principal Supervisor Resilience, Psychosis and Childhood Trauma Doctor of Philosophy Doctorate Full Time Mr Shaun Michael David Sweeney
2007 - 2012 Co-Supervisor The Role of Cognitive Biases in the Development, Maintenance and Treatment of Delusional Belief across the Psychosis Continuum Doctor of Philosophy Doctorate Full Time Dr Ryan Balzan
2007 - 2013 Co-Supervisor A Qualitative Study of Medication Adherence Amongst People with Schizophrenia Master of Psychology (Clinical)/Doctor of Philosophy Doctorate Full Time Ms Lucinda Clifford

Date Role Committee Institution Country
2015 - ongoing Member SA Psychiatry Training Committee - -
2015 - ongoing Co-Chair Scientific Committee, RANZCP Annual Congress, Adelaide 2017 - -
2013 - 2016 Chair Working group to revise RANZCP Clinical Practise Guidelines on Schizophrenia and Related Disorders RANZCP Australia
2011 - ongoing Chair MBBS Year 6 Course Committee The University of Adelaide -
2011 - ongoing Member MBBS Curriculum Committee The University of Adelaide -
2011 - ongoing Member MBBS Assessment Committee The University of Adelaide -
2006 - ongoing Member Medical Advisory Committee Ramsay Health Care (SA) Mental Health -
2006 - ongoing Member Research Committee, School of Medicine The University of Adelaide -

Date Role Membership Country
2010 - ongoing - Australian Medical Association -
2010 - ongoing - Society for Mental Health Research -
2010 - 2019 Member European Association of Threat Assessment Professionals Australia
2010 - 2018 Member Collegium Internationale Neuro-psychopharmacologium Australia
2010 - 2018 Member European College of Neuropsychopharmacology Australia
2010 - 2017 Member International Society for Affective Disorders Australia
2010 - ongoing - Royal Australian & New Zealand College of Psychiatrists -
2010 - ongoing - RANZCP Section for Neurosciences -
2010 - ongoing - Schizophrenia International Research Society -

Date Role Editorial Board Name Institution Country
2014 - ongoing Board Member Andhra Pradesh Journal of Psychological Medicine - -
2013 - ongoing Editor Schizophrenia, Frontiers in Psychiatry Schizophrenia, Frontiers in Psychiatry Australia
2011 - 2021 Associate Editor Australian and New Zealand Journal of Psychiatry Australian and New Zealand Journal of Psychiatry Australia
2011 - 2020 Member Editorial Executive Committee, Australian Prescriber (National Prescribing Service) Australian Prescriber Australia
2011 - ongoing Consulting Editor World Journal of Pharmacology - -

Connect With Me

External Profiles

Other Links